M

MetaHeps GmbH

10 employees

MetaHeps provides solutions for drug-induced liver injury (DILI) in clinical drug-development and postmarketing.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Consulting

Date founded

2014

Funding rounds raised

M

MetaHeps GmbH raised undisclosed on January 1, 2017

Investors: European Commission

M

MetaHeps GmbH raised undisclosed on January 1, 2016

Investors: EIT Health

M

MetaHeps GmbH raised undisclosed on December 1, 2015

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ